Hematopoietic Dysfunction in a Mouse Model for Fanconi Anemia Group D1

Slides:



Advertisements
Similar presentations
Volume 17, Issue 6, Pages (June 2009)
Advertisements

Joseph H. Chewning, Weiwei Zhang, David A. Randolph, C
Volume 15, Issue 1, Pages (July 2014)
Stromal-Derived Factor-1α and Interleukin-7 Treatment Improves Homeostatic Proliferation of Naïve CD4+ T Cells after Allogeneic Stem Cell Transplantation 
Continuous in vivo infusion of interferon-gamma (IFN-γ) enhances engraftment of syngeneic wild-type cells in Fanca–/– and Fancg–/– mice by Yue Si, Samantha.
Characterization and quantification of clonal heterogeneity among hematopoietic stem cells: a model-based approach by Ingo Roeder, Katrin Horn, Hans-Bernd.
Volume 12, Issue 1, Pages (January 2013)
Volume 25, Issue 9, Pages (September 2017)
Volume 129, Issue 6, Pages (June 2007)
Jacob Andrade, Shundi Ge, Goar Symbatyan, Michael S. Rosol, Arthur J
Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc −/− hematopoietic stem cells and decreases the risk of clonal.
Low c-Kit Expression Level Induced by Stem Cell Factor Does Not Compromise Transplantation of Hematopoietic Stem Cells  Chia-Ling Chen, Katerina Faltusova,
Volume 17, Issue 9, Pages (September 2009)
TLR5 signaling in murine bone marrow induces hematopoietic progenitor cell proliferation and aids survival from radiation by Benyue Zhang, Damilola Oyewole-Said,
Volume 10, Issue 3, Pages (September 2004)
Jacob Andrade, Shundi Ge, Goar Symbatyan, Michael S. Rosol, Arthur J
Volume 3, Issue 5, Pages (November 2014)
Volume 25, Issue 3, Pages (March 2017)
Lentiviral-mediated RNAi inhibition of Sbds in murine hematopoietic progenitors impairs their hematopoietic potential by Amy S. Rawls, Alyssa D. Gregory,
Volume 17, Issue 10, Pages (December 2016)
Volume 2, Issue 4, Pages (April 2008)
Volume 123, Issue 6, Pages (December 2005)
Christine V. Ichim, Džana D
Leukemia and chromosomal instability in aged Fancc−/− mice
Volume 4, Issue 2, Pages (February 2003)
HOXB4-Induced Expansion of Adult Hematopoietic Stem Cells Ex Vivo
Volume 25, Issue 9, Pages (September 2017)
Mark J. Kiel, Melih Acar, Glenn L. Radice, Sean J. Morrison 
Volume 19, Issue 5, Pages (November 2003)
T Cell and B Cell Immunity can be Reconstituted with Mismatched Hematopoietic Stem Cell Transplantation Without Alkylator Therapy in Artemis-Deficient.
The Competitive Nature of HOXB4-Transduced HSC Is Limited by PBX1
Volume 4, Issue 1, Pages (January 2015)
Volume 21, Issue 2, Pages (February 2013)
Juana Serrano-Lopez, Kalpana Nattamai, Nicholas A. Pease, Miranda S
Volume 25, Issue 8, Pages (August 2017)
Volume 14, Issue 12, Pages (March 2016)
In Situ Activation and Expansion of Host Tregs: A New Approach to Enhance Donor Chimerism and Stable Engraftment in Major Histocompatibility Complex-Matched.
Volume 11, Issue 3, Pages (September 2018)
Ravindra Majeti, Christopher Y. Park, Irving L. Weissman 
Recipient B Cells Are Not Required for Graft-Versus-Host Disease Induction  Catherine Matte-Martone, Xiajian Wang, Britt Anderson, Dhanpat Jain, Anthony.
Volume 9, Issue 1, Pages (July 2011)
Volume 10, Issue 6, Pages (December 2004)
Volume 13, Issue 2, Pages (February 2006)
Volume 9, Issue 2, Pages (August 2011)
Volume 9, Issue 4, Pages (November 2014)
Volume 1, Issue 3, Pages (September 2007)
Ex vivo gene therapy using bone marrow-derived cells: combined effects of intracerebral and intravenous transplantation in a mouse model of niemann–pick.
Volume 6, Issue 3, Pages (March 2010)
Volume 4, Issue 2, Pages (February 2009)
Volume 17, Issue 4, Pages (October 2002)
Volume 3, Issue 2, Pages (August 2008)
Volume 2, Issue 1, Pages (January 2008)
Kiran Batta, Magdalena Florkowska, Valerie Kouskoff, Georges Lacaud 
Volume 8, Issue 6, Pages (December 2003)
Volume 8, Issue 1, Pages (January 2011)
Volume 15, Issue 8, Pages (August 2007)
by Yue Wei, Hong Zheng, Naran Bao, Shan Jiang, Carlos E
Volume 11, Issue 6, Pages (June 2005)
Volume 13, Issue 1, Pages (January 2006)
Volume 16, Issue 2, Pages (February 2009)
Volume 7, Issue 2, Pages (August 2010)
Volume 1, Issue 2, Pages (August 2007)
Volume 21, Issue 12, Pages (December 2017)
SLAM Family Markers Resolve Functionally Distinct Subpopulations of Hematopoietic Stem Cells and Multipotent Progenitors  Hideyuki Oguro, Lei Ding, Sean J.
Volume 2, Issue 3, Pages (March 2008)
All Hematopoietic Stem Cells Engraft in Submyeloablatively Irradiated Mice  Katarina Forgacova, Filipp Savvulidi, Ludek Sefc, Jana Linhartova, Emanuel.
Molecular Therapy - Methods & Clinical Development
Nitric Oxide Is a Regulator of Hematopoietic Stem Cell Activity
Volume 7, Issue 1, Pages (July 2010)
Volume 17, Issue 6, Pages (June 2009)
Presentation transcript:

Hematopoietic Dysfunction in a Mouse Model for Fanconi Anemia Group D1 Susana Navarro, Nestor W. Meza, Oscar Quintana-Bustamante, José A. Casado, Ariana Jacome, Kimberly McAllister, Silvia Puerto, Jordi Surrallés, José C. Segovia, Juan A. Bueren  Molecular Therapy  Volume 14, Issue 4, Pages 525-535 (October 2006) DOI: 10.1016/j.ymthe.2006.05.018 Copyright © 2006 The American Society of Gene Therapy Terms and Conditions

FIG. 1 Analysis of the cellularity and hematopoietic colony-forming cells in the bone marrow and spleen of Brca2Δ27/Δ27 mice compared to age-matched Brca2+/Δ27 and WT mice. Data represent the mean ± SEM values corresponding to three to five mice per group. (A) Data corresponding to 8- to 12-week-old mice are shown. (B) Data corresponding to 1.5-week-old mice. *Statistical significance between the Brca2Δ27/Δ27 and WT groups (P < 0.05). Molecular Therapy 2006 14, 525-535DOI: (10.1016/j.ymthe.2006.05.018) Copyright © 2006 The American Society of Gene Therapy Terms and Conditions

FIG. 2 Proliferation defect in hematopoietic colony-forming cells from Brca2Δ27/Δ27 mice. (A) The distribution of large, medium, and small colonies generated by the bone marrow from WT, Brca2+/Δ27, and Brca2Δ27/Δ27 mice (three animals per group). Representative colonies from each category are shown. (B) The cumulative number of viable cells and proportion of CFCs in bone marrow cultures from WT (open symbols) and Brca2Δ27/Δ27 (filled symbols) mice subjected to ex vivo expansion (see Materials and Methods). The means ± SEM of data corresponding to four different experiments, each with a different bone marrow sample, are shown. *Significant differences with respect to WT samples (P < 0.05). Molecular Therapy 2006 14, 525-535DOI: (10.1016/j.ymthe.2006.05.018) Copyright © 2006 The American Society of Gene Therapy Terms and Conditions

FIG. 3 Mitomycin C sensitivity and chromosomal instability of bone marrow progenitors from Brca2Δ27/Δ27 mice. (A) Analysis of the sensitivity of bone marrow progenitors from WT (open symbols), Brca2+/Δ27 (gray symbols), and Brca2Δ27/Δ27 (black symbols) mice to mitomycin C (MMC). Each point represents the mean ± SEM corresponding to three experiments. (B) Analysis of the number of chromatid breaks in bone marrow cells from WT, Fanca−/−, Brca2+/Δ27, and Brca2Δ27/Δ27 mice in the absence (−) or the presence (+) of 30 nM MMC. Data from one representative experiment are shown. A minimum of 50 metaphases were scored in each case. (C) Representative metaphase spreads showing spontaneous and MMC-induced chromatid breaks (arrows) and interchromatid exchanges, such as radial and complex figures (arrowheads) in WT, Fanca−/−, and Brca2Δ27/Δ27 bone marrow cells. Molecular Therapy 2006 14, 525-535DOI: (10.1016/j.ymthe.2006.05.018) Copyright © 2006 The American Society of Gene Therapy Terms and Conditions

FIG. 4 Impaired response of Brca2Δ27/Δ27 mice to ionizing radiation. (A) Pictures show representative analyses of Rad51 foci in fibroblasts from WT and Brca2Δ27/Δ27 mice. (−/+ IR, cells were sham-irradiated or irradiated with 12 Gy.) (B) Survival curves of bone marrow CFCs from WT (open symbols), Brca2+/Δ27 (gray symbols), and Brca2Δ27/Δ27 (black symbols) mice after in vitro irradiation. Survival data were adjusted to the multitarget model, as previously described [23]. The parameters obtained from the mathematical model were the following: WT, Do = 0.91 Gy, n = 4.9; Brca2+/Δ27, Do = 1.13 Gy, n = 2.0; Brca2Δ27/Δ27, Do = 0.94 Gy, n = 2.3. (C) Hematopoietic syndrome of WT (open symbols) and Brca2Δ27/Δ27 (filled symbols) mice exposed to total body irradiation (5 doses of 1 Gy delivered at 24-h intervals). Seven days after the irradiation protocol was started, numbers of leukocytes (WBCs), erythrocytes (RBCs), and platelets were periodically analyzed in peripheral blood. Molecular Therapy 2006 14, 525-535DOI: (10.1016/j.ymthe.2006.05.018) Copyright © 2006 The American Society of Gene Therapy Terms and Conditions

FIG. 5 Defective competitive repopulation ability of hematopoietic stem cells from Brca2Δ27/Δ27 mice. (A) Experimental approach used to determine the competitive repopulation ability (CRA) of hematopoietic stem cells from WT and Brca2Δ27/Δ27 mice (see Materials and Methods). (B) Competitive repopulation ability of Brca2Δ27/Δ27 stem cells (black bars) compared to that observed in control WT mice (white bars). Relative values of CRA from Brca2Δ27/Δ27 with respect to WT stem cells are shown in parentheses. In all instances the level of endogenous reconstitution of the irradiated recipients was below 10%. *Statistical significance between the WT and the Brca2Δ27/Δ27 groups (P < 0.05). Molecular Therapy 2006 14, 525-535DOI: (10.1016/j.ymthe.2006.05.018) Copyright © 2006 The American Society of Gene Therapy Terms and Conditions

FIG. 6 Proliferation advantage of wild-type hematopoietic stem cells transplanted into unconditioned Brca2Δ27/Δ27 mice. (A) Experimental protocol used for evaluating the regeneration capacity of Brca2Δ27/Δ27 HSCs under steady-state physiological conditions. In these experiments, bone marrow cells (either 2 × 106 or 2 × 107 cells) from male WT mice were transplanted into unconditioned female recipients (either WT or Brca2Δ27/Δ27; see details under Materials and Methods). (B) Analysis of engraftment of donor WT cells in WT (open symbols) and Brca2Δ27/Δ27 (filled symbols) recipients determined by RT-qPCR in peripheral blood cells. Individual data corresponding to recipients transplanted with 2 × 107 BM cells are shown. (#) Engrafted mice. (C) Representative in situ hybridization analyses of the Y chromosome in bone marrow samples from WT and Brca2Δ27/Δ27 unconditioned recipients transplanted with WT bone marrow cells, as indicated in (A). Bone marrow samples were analyzed 6 months after transplantation. (D) Partial reversion of the MMC sensitivity of bone marrow progenitors from Brca2Δ27/Δ27 mice produced as a consequence of the transplantation of 2 × 107 WT BM cells. (#) Data from the three engrafted mice in (B). (E) Sustained repopulation of WT primary bone marrow cells in myeloablated secondary recipients. Bone marrow from unconditioned primary recipients, WT (open symbols) and Brca2Δ27/Δ27 (filled symbols) mice, was harvested 6 months after transplantation and then infused into irradiated secondary recipients. The level of endogenous reconstitution of secondary recipients was always below 10%. Molecular Therapy 2006 14, 525-535DOI: (10.1016/j.ymthe.2006.05.018) Copyright © 2006 The American Society of Gene Therapy Terms and Conditions